# A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With Immune Modulators (Staphylococcus and Neisseria Tablets)

> **NCT06895460** · PHASE3 · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 198 (estimated)

## Conditions studied

- Bronchial Asthma

## Interventions

- **DRUG:** Budesonide Formoterol
- **DRUG:** Placebo
- **DRUG:** Immune Modulators (Staphylococcus and Neisseria Tablets)

## Key facts

- **NCT ID:** NCT06895460
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-20
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 198 (ESTIMATED)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06895460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06895460, "A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With Immune Modulators (Staphylococcus and Neisseria Tablets)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06895460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*